Innoviva, Inc. (INVA)
Pharmaceutical Preparations · Healthcare · $4.9B
Intrinsic Value (Consensus)
$64.20
Current Price
$66.00
Margin of Safety
-2.7%
2.7% Above Intrinsic Value
Value: $64
Price: $66
Valuation Model Estimates
Current Price: $66.00
DCF (Discounted Cash Flow)
$124.40
Graham Number
$34.35
Earnings Power Value
$32.04
Relative Value (P/E)
$66.00
Dividend Discount Model
Not applicable
—
Consensus Value
$64.20
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Key Financials
- EPS (TTM)
- $3.30
- EPS (Forward)
- $3.96
- Book Value
- $15.89
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 0.4%
- Debt/Equity
- 64%
- Revenue Growth
- 14.7%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Data last updated: 2026-06-12
Source: Yahoo Finance